Daniel D. Long

SEPN

Daniel D. Long serves as SVP, Drug Discovery at Septerna, Inc. (SEPN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$63.2K

Net Position

Net Seller

$63.2K

Companies Traded

SEPN

Active Period

Nov 2025

1 total trades

Most Recent

Sell SEPN

Nov 13, 2025 · $63.2K

Daniel D. Long's Insider Trading at Septerna, Inc. (SEPN)

Buys

0 · $0.00

Sells

1 · $63.2K

Total Shares Bought

Total Shares Sold

3,501

SEPN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 13, 2025↗	Sell	3,501	$18.06	$63.2K	92,911

Related Insiders

Samira Shaikhly

officer: Chief People Officer

SEPNSell · Mar 2, 2026

Elizabeth Bhatt

officer: President and COO

SEPNSell · Feb 18, 2026

Elizabeth Bhatt

President and COO

SEPNSell · Feb 18, 2026

Explore More Insider Trading Data

SEPN Insider Trading Activity

View all insider trades at Septerna, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity